Masimo Corporation (MASI) is up 34.08% today. Here is some analysis on what might have caused this price movement.
Analysis: The stock surged after Masimo agreed to be acquired by Danaher in an all-cash deal, giving investors a clear, near-term valuation anchor. The move largely reflects the gap between Masimo’s prior close and the $180-per-share offer price, adjusted for deal-completion risk and timing.
Details:
Sources:
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$MASI Insider Trading Activity
$MASI insiders have traded $MASI stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $MASI stock by insiders over the last 6 months:
- ANAND SAMPATH (EVP, Ops & Clinical Research) has made 0 purchases and 3 sales selling 18,680 shares for an estimated $2,555,570.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$MASI Hedge Fund Activity
We have seen 169 institutional investors add shares of $MASI stock to their portfolio, and 220 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 1,505,472 shares (-14.5%) from their portfolio in Q4 2025, for an estimated $195,801,688
- HOLOCENE ADVISORS, LP removed 1,243,607 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $183,494,212
- CAPITAL RESEARCH GLOBAL INVESTORS removed 1,216,234 shares (-65.6%) from their portfolio in Q4 2025, for an estimated $158,183,394
- ALLIANCEBERNSTEIN L.P. removed 790,506 shares (-93.7%) from their portfolio in Q3 2025, for an estimated $116,639,160
- DURABLE CAPITAL PARTNERS LP removed 543,279 shares (-46.7%) from their portfolio in Q3 2025, for an estimated $80,160,816
- VANGUARD GROUP INC removed 461,225 shares (-9.6%) from their portfolio in Q4 2025, for an estimated $59,986,923
- UBS GROUP AG added 429,474 shares (+252.9%) to their portfolio in Q4 2025, for an estimated $55,857,388
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$MASI Government Contracts
We have seen $1,115,500 of award payments to $MASI over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- MASIMO ROOT PLATFORM SYSTEM: $130,396
- 4568591237!MIGHTYSAT, OXIMETER, RX,1/BX,US: $54,280
- 4567819755!CAPNOMETER EMMA 1S: $51,600
- 4568325430!CAPNOMETER EMMA 1S: $46,800
- 4567385447!CAPNOMETER EMMA 1S: $43,200
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$MASI Congressional Stock Trading
Members of Congress have traded $MASI stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MASI stock by members of Congress over the last 6 months:
- REPRESENTATIVE KEVIN HERN sold up to $50,000 on 09/26.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$MASI Analyst Ratings
Wall Street analysts have issued reports on $MASI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 12/04/2025
To track analyst ratings and price targets for $MASI, check out Quiver Quantitative's $MASI forecast page.
$MASI Price Targets
Multiple analysts have issued price targets for $MASI recently. We have seen 3 analysts offer price targets for $MASI in the last 6 months, with a median target of $187.0.
Here are some recent targets:
- Marie Thibault from BTIG set a target price of $200.0 on 12/04/2025
- Travis Steed from B of A Securities set a target price of $162.0 on 11/17/2025
- Vik Chopra from Wells Fargo set a target price of $187.0 on 11/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.